Alterations in the Ca 2+ toolkit in oesophageal adenocarcinoma.
Alana L CutliffeSharon L McKennaDarshan S ChandrashekarAlvin Wei Tian NgGinny DevonshireRebecca C FitzgeraldTracey R O'DonovanJohn James MackrillPublished in: Exploration of targeted anti-tumor therapy (2021)
signalling findings are consistent with those from studies on other cancers. Genes that were consistently upregulated in both datasets might represent useful markers for patient diagnosis. Genes that were consistently upregulated, and which were associated with improved survival, might be useful markers for patient outcome. These survival-associated genes may also represent targets for the development of novel chemotherapeutic agents.